Regulatory Disclosures

Investor Relations

The following disclosures are made pursuant to the Banking (Disclosure) Rules.

Capital instruments currently included in the Bank’s capital base: Full terms and conditions of capital instruments included in the Bank’s capital base
Ordinary shares

30 September 2025: Quarterly financial disclosures

30 June 2025: Full terms and conditions of capital instruments included in the Bank’s capital base
Ordinary shares

Regulatory Disclosures Statement
Regulatory Disclosures Statement

31 March 2025: Quarterly financial disclosures

31 December 2024: Full terms and conditions of capital instruments included in the Bank’s capital base
Ordinary shares

Regulatory Disclosures Statement
Regulatory Disclosures Statement

30 September 2024: Quarterly financial disclosures

30 June 2024: Full terms and conditions of capital instruments included in the Bank’s capital base
Ordinary shares

Regulatory Disclosures Statement
Regulatory Disclosures Statement

31 March 2024: Quarterly financial disclosures

31 December 2023: Full terms and conditions of capital instruments included in the Bank’s capital base
Ordinary shares

Regulatory Disclosures Statement
Regulatory Disclosures Statement

30 September 2023: Quarterly financial disclosures

30 June 2023: Full terms and conditions of capital instruments included in the Bank’s capital base
Ordinary shares

Regulatory Disclosures Statement
Regulatory Disclosures Statement

31 March 2023: Quarterly financial disclosures

31 December 2022: Full terms and conditions of capital instruments included in the Bank’s capital base
Ordinary shares

Regulatory Disclosures Statement
Regulatory Disclosures Statement

30 September 2022: Quarterly financial disclosures

30 June 2022: Full terms and conditions of capital instruments included in the Bank’s capital base
Ordinary shares

Regulatory Disclosures Statement
Regulatory Disclosures Statement

31 March 2022: Quarterly financial disclosures

31 December 2021: Full terms and conditions of capital instruments included in the Bank’s capital base
Ordinary shares

Regulatory Disclosures Statement
Regulatory Disclosures Statement

30 September 2021: Quarterly financial disclosures

30 June 2021: Full terms and conditions of capital instruments included in the Bank’s capital base
Ordinary shares

Regulatory Disclosures Statement
Regulatory Disclosures Statement

31 March 2021: Quarterly financial disclosures

31 December 2020: Full terms and conditions of capital instruments included in the Bank’s capital base
Ordinary shares

Regulatory Disclosures Statement
Regulatory Disclosures Statement

30 September 2020: Quarterly financial disclosures

30 June 2020: Full terms and conditions of capital instruments included in the Bank’s capital base
Ordinary shares
USD200 million subordinated notes issued

Regulatory Disclosures Statement
Regulatory Disclosures Statement

31 March 2020: Quarterly financial disclosures

31 December 2019: Full terms and conditions of capital instruments included in the Bank’s capital base
Ordinary shares
USD200 million subordinated notes issued

Regulatory Disclosures Statement
Regulatory Disclosures Statement

30 September 2019: Quarterly financial disclosures

30 June 2019: Full terms and conditions of capital instruments included in the Bank’s capital base
Ordinary shares
USD200 million subordinated notes issued

Regulatory Disclosures Statement
Regulatory Disclosures Statement

31 March 2019: Quarterly financial disclosures

31 December 2018: Full terms and conditions of capital instruments included in the Bank’s capital base (available in English version only)
Ordinary shares
USD200 million subordinated notes issued

Regulatory Disclosures Statement
Regulatory Disclosures Statement

30 September 2018: Quarterly financial disclosures

30 June 2018: Full terms and conditions of capital instruments included in the Bank’s capital base (available in English version only)
Ordinary shares
USD200 million subordinated notes issued
USD193 million non-cumulative subordinated additional tier 1 capital securities

Pillar 3 regulatory disclosures
Pillar 3 regulatory disclosures

31 March 2018: Quarterly financial disclosures

31 December 2017: Capital Disclosures
Transition disclosures template
Balance sheet reconciliation
Main features of capital instruments

Full terms and conditions of capital instruments included in the Bank’s capital base (available in English version only)
Ordinary shares
USD200 million subordinated notes issued
USD193 million non-cumulative subordinated additional tier 1 capital securities

Leverage Ratio
Leverage ratio summary comparison table
Leverage ratio common disclosure template

Countercyclical Capital Buffer (CCyB) Ratio
Countercyclical Capital Buffer (CCyB) Ratio Standard Disclosure Template

Pillar 3 regulatory disclosures
Pillar 3 regulatory disclosures

30 September 2017: Quarterly financial disclosures

30 June 2017: Capital Disclosures
Transition disclosures template
Balance sheet reconciliation
Main features of capital instruments
Full terms and conditions of capital instruments included in the Bank’s capital base (available in English version only)
- Ordinary shares
- USD200 million subordinated notes issued

Leverage Ratio
Leverage ratio summary comparison table
Leverage ratio common disclosure template

Countercyclical Capital Buffer (CCyB) Ratio
Countercyclical Capital Buffer (CCyB) Ratio Standard Disclosure Template

31 March 2017: Quarterly financial disclosures

31 December 2016: Capital Disclosures
Transition disclosures template
Balance sheet reconciliation
Main features of capital instruments
Full terms and conditions of capital instruments included in the Bank’s capital base (available in English version only)
- Ordinary shares
- USD200 million subordinated notes issued

Leverage Ratio
Leverage ratio summary comparison table
Leverage ratio common disclosure template

Countercyclical Capital Buffer (CCyB) Ratio
Countercyclical Capital Buffer (CCyB) Ratio Standard Disclosure Template

30 June 2016: Capital Disclosures
Transition disclosures template
Balance sheet reconciliation
Main features of capital instruments
Full terms and conditions of capital instruments included in the Bank’s capital base (available in English version only)
- Ordinary shares
- USD200 million subordinated notes issued

Leverage Ratio
Leverage ratio summary comparison table
Leverage ratio common disclosure template

Countercyclical Capital Buffer (CCyB) Ratio
Countercyclical Capital Buffer (CCyB) Ratio Standard Disclosure Template

31 December 2015: Capital Disclosures
Transition disclosures template
Balance sheet reconciliation
Main features of capital instruments
Full terms and conditions of capital instruments included in the Bank’s capital base (available in English version only)
- Ordinary shares
- USD200 million subordinated notes issued

Leverage Ratio
Leverage ratio summary comparison table
Leverage ratio common disclosure template

30 June 2015: Capital Disclosures
Transition disclosures template
Balance sheet reconciliation
Main features of capital instruments
Full terms and conditions of capital instruments included in the Bank’s capital base (available in English version only)
- Ordinary shares
- USD200 million subordinated notes issued

Leverage Ratio
Leverage ratio summary comparison table
Leverage ratio common disclosure template

31 December 2014: Transition disclosures template
Balance sheet reconciliation
Main features of capital instruments
Full terms and conditions of capital instruments included in the Bank’s capital base (available in English version only)
- Ordinary shares
- USD200 million subordinated notes issued

30 June 2014: Transition disclosures template
Balance sheet reconciliation
Main features of capital instruments
Full terms and conditions of capital instruments included in the Bank’s capital base (available in English version only)
- Ordinary shares
- USD200 million subordinated notes issued

31 December 2013: Transition disclosures template
Balance sheet reconciliation
Main features of capital instruments
Full terms and conditions of capital instruments included in the Bank’s capital base (available in English version only)
- Ordinary shares
- USD200 million subordinated notes issued

30 June 2013: Transition disclosures template
Balance sheet reconciliation
Main features of capital instruments
Full terms and conditions of capital instruments included in the Bank’s capital base (available in English version only)
- Ordinary shares
- Preference shares
- USD200 million subordinated notes issued